Journal Title：Neurology-neuroimmunology & Neuroinflammation

Neurology: Neuroimmunology & NeuroInflammation is an official journal of the American Academy of Neurology.

Vision: Our vision is to be the premier peer-reviewed journal for experts in the fields of neuroimmunology and neuroinflammation.

Mission: The mission of Neurology Neuroimmunology & Neuroinflammation is to provide neurologists and translationally minded scientists with peer-reviewed articles, editorials, and reviews to enhance patient care, education, and clinical & translational research.

We publish rigorously peer-reviewed open access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to): Alzheimer disease, Parkinson disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.

神經(jīng)病學(xué)：《神經(jīng)免疫學(xué)與神經(jīng)炎癥》是美國神經(jīng)病學(xué)學(xué)會的官方期刊。

愿景：我們的愿景是成為神經(jīng)免疫學(xué)和神經(jīng)炎癥領(lǐng)域?qū)＜业氖浊恢傅耐性u審期刊。

使命：《神經(jīng)病學(xué)：神經(jīng)免疫學(xué)與神經(jīng)炎癥》的使命是為神經(jīng)病學(xué)家和具有轉(zhuǎn)化思維的科學(xué)家提供同行評審的文章、社論和評論，以加強(qiáng)患者護(hù)理、教育以及臨床和轉(zhuǎn)化研究。

我們發(fā)表經(jīng)過嚴(yán)格同行評審的開放獲取原創(chuàng)研究報(bào)告和神經(jīng)免疫學(xué)與神經(jīng)炎癥主題的深入評論，影響各種神經(jīng)系統(tǒng)疾病，包括（但不限于）：阿爾茨海默病、帕金森病、ALS、tau 蛋白病和中風(fēng)；多發(fā)性硬化癥和 NMO；炎癥性周圍神經(jīng)和肌肉疾病、格林-巴利綜合征和重癥肌無力；神經(jīng)系統(tǒng)感染；副腫瘤綜合征、非感染性腦炎和其他抗體介導(dǎo)的疾??；以及精神和神經(jīng)發(fā)育障礙。還將介紹臨床試驗(yàn)、指導(dǎo)性病例報(bào)告和小型病例系列。

Neurology-neuroimmunology & Neuroinflammation創(chuàng)刊于2014年，由Lippincott Williams and Wilkins Ltd.出版商出版，收稿方向涵蓋Neuroscience - Neurology全領(lǐng)域，在行業(yè)領(lǐng)域中學(xué)術(shù)影響力很大，屬于TOP期刊，國際一流期刊，關(guān)注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于TOP期刊，建議關(guān)注此刊。平均審稿速度 8 Weeks ，影響因子指數(shù)7.8，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。